Hepatocellular Carcinoma Mortality Rates Rising in the US, Driven by Alcohol and Metabolic Liver Dis | Docwire News
Rising HCC mortality rates in the US highlight stark disparities across age, sex, race, and liver disease etiologies.
Related Articles
Team Develops System to Predict Urothelial Carcinoma Outcomes With Enfortumab Vedotin | Cancer Nursing Today
A risk classification system using C-reactive protein (CRP) levels and hypercalcemia is “useful for predicting the outcomes” of patients receiving enfortumab vedotin.
The Phase 3 CLARIFY Trial With 64Cu-SAR-bisPSMA: A Next-Generation PSMA Imaging Agent | GU Oncology Now
David Morris, MD, FACS, of Urology Associates of Nashville, discusses the emerging role of copper-based PSMA imaging agents, specifically Clarity Pharmaceuticals’ 64Cu-SAR-bisPSMA.
AMPLIFY Data Reveals Advantages of All-Oral BTKi Therapy is Treatment-Naïve CLL | Blood Cancers Today
The phase 3 AMPLIFY study provides evidence that fixed-duration acalabrutinib plus venetoclax may be a valid treatment option for fit patients with treatment-naive CLL.
The Association of Echocardiographically Measured Donor Left Ventricular Mass and 1-Year Outcomes After Heart Transplantation:
AbstractBackgroundDonor-recipient heart size matching is crucial in heart transplantation; however, the often-used predicted heart mass (PHM) ratio may be inaccurate in the setting of obesity.Objec…
How Bone Metastasis Impacts NSCLC Outcomes With Immune Checkpoint Inhibitors | Docwire News
The retrospective analysis reaffirmed evidence from CCTG BR.34 that showed bone metastasis was associated with worse outcomes in ICI-treated NSCLC, with or without chemotherapy.
Kidney Outcomes After ARNI Versus ACEI/ARB for mHTN-Related TMA | Docwire News
A study evaluated kidney outcomes of angiotensin receptor-neprilysin inhibitor therapy versus ACEI/ARB for thrombotic microangiopathy related to malignant hypertension.
An Automated Machine Learning–Based Quantitative Multiparametric Approach for Mitral Regurgitation Severity Grading:
AbstractBackgroundConsidering the high prevalence of mitral regurgitation (MR) and the highly subjective, variable MR severity reporting, an automated tool that could screen patients for clinically…
FDA Approves New Drug to Treat a Serious Immune Condition that Can Affect Children with Blood Cancer | Leukemia and Lymphoma Society
FDA Approves New Drug to Treat a Serious Immune Condition that Can Affect Children with Blood Cancer > Page Components
Diagnostic Role of Endoscopic Ultrasound in Cardiac Angiosarcoma:
AbstractPrimary cardiac tumors are a rare disease, with 20% of the cases being malignant. Among them, angiosarcoma is characterized by a short clinical course and…
Venetoclax and CLL: How Much TLS Monitoring Is Really Necessary? | Blood Cancers Today
The standard strategy for TLS mitigation is dose escalation and TLS monitoring during dose ramp-up, and there is an ongoing debate on whether the standard…